Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines

Experimental Neurology

Volumn 250, Issue , 2013, Pages 143-150

  Payne, Andrew J ^a   Gerdes, Bryan C ^a   Naumchuk, Yuliya ^a   McCalley, Audrey E ^a   Kaja, Simon ^a   Koulen, Peter ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Endoplasmic reticulum; Intracellular calcium; Neuroprotection; Oxidative stress

Indexed keywords

CALCIUM ION; PRESENILIN; RYANODINE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

ALZHEIMER'S DISEASE; ENDOPLASMIC RETICULUM; INTRACELLULAR CALCIUM; NEUROPROTECTION; OXIDATIVE STRESS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CALCIUM; CALCIUM SIGNALING; CELL LINE; CYSTEINE; ENDOPLASMIC RETICULUM; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEURONS; PEPTIDES; PRESENILINS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84885802576     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.001     Document Type: Article

References (51)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2012, 8:131-168.
2. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. Nat. Genet. 1995, 11:219-222. Alzheimer's Disease Collaborative Group.
3. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 1996, 17:1005-1013.
4. Borghi R., Piccini A., Barini E., Cirmena G., Guglielmotto M., Tamagno E., Fornaro M., Perry G., Smith M.A., Garuti A., Tabaton M. Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease. J. Alzheimers Dis. 2010, 22(3):771-775.
5. Burroughs S.L., Duncan R.S., Rayudu P., Kandula P., Payne A.J., Clark J.L., Koulen P., Kaja S. Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures. J. Neurosci. Methods 2012, 203:141-145.
6. Cedazo-Minguez A., Popescu B.O., Ankarcrona M., Nishimura T., Cowburn R.F. The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J. Biol. Chem. 2002, 277:36646-36655.
7. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 2000, 275:18195-18200.
8. Cheung K.H., Shineman D., Muller M., Cardenas C., Mei L., Yang J., Tomita T., Iwatsubo T., Lee V.M., Foskett J.K. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008, 58:871-883.
9. Cheung K.H., Mei L., Mak D.O., Hayashi I., Iwatsubo T., Kang D.E., Foskett J.K. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Sci. Signal. 2010, 3:ra22.
10. Cowburn R.F., Popescu B.O., Ankarcrona M., Dehvari N., Cedazo-Minguez A. Presenilin-mediated signal transduction. Physiol. Behav. 2007, 92:93-97.
11. Cumming R.C., Andon N.L., Haynes P.A., Park M., Fischer W.H., Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 2004, 279:21749-21758.
12. Demuro A., Parker I., Stutzmann G.E. Calcium signaling and amyloid toxicity in Alzheimer disease. J. Biol. Chem. 2010, 285:12463-12468.
13. Donoviel D.B., Hadjantonakis A.K., Ikeda M., Zheng H., Hyslop P.S., Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 1999, 13:2801-2810.
14. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713.
15. Elder G.A., Gama Sosa M.A., De Gasperi R., Dickstein D.L., Hof P.R. Presenilin transgenic mice as models of Alzheimer's disease. Brain Struct. Funct. 2010, 214:127-143.
16. Flood F., et al. Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line. Neurochem. Int. 2004, 44(7):487-496.
17. Goussakov I., Miller M.B., Stutzmann G.E. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J. Neurosci. 2010, 30:12128-12137.
18. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 1999, 5:101-106.
19. Hayrapetyan V., Rybalchenko V., Rybalchenko N., Koulen P. The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. Cell Calcium 2008, 44:507-518.
20. Hwang S.Y., Wei J., Westhoff J.H., Duncan R.S., Ozawa F., Volpe P., Inokuchi K., Koulen P. Differential functional interaction of two Vesl/Homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium 2003, 34:177-184.
21. Kasri N.N., Kocks S.L., Verbert L., Hebert S.S., Callewaert G., Parys J.B., Missiaen L., De Smedt H. Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 2006, 40:41-51.
22. Koulen P., Thrower E.C. Pharmacological modulation of intracellular Ca(2+) channels at the single-channel level. Mol. Neurobiol. 2001, 24:65-86.
23. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002, 3:862-872.
24. Lee S.Y., Hwang D.Y., Kim Y.K., Lee J.W., Shin I.C., Oh K.W., Lee M.K., Lim J.S., Yoon D.Y., Hwang S.J., Hong J.T. PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. FASEB J. 2006, 20:151-153.
25. Leissring M.A., Parker I., LaFerla F.M. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals. J. Biol. Chem. 1999, 274:32535-32538.
26. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
27. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
28. Mattson M.P. ER calcium and Alzheimer's disease: in a state of flux. Sci. Signal. 2010, 3:pe10.
29. Meyers M.B., Pickel V.M., Sheu S.S., Sharma V.K., Scotto K.W., Fishman G.I. Association of sorcin with the cardiac ryanodine receptor. J. Biol. Chem. 1995, 270:26411-26418.
30. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
31. Rybalchenko V., Hwang S.Y., Rybalchenko N., Koulen P. The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int. J. Biochem. Cell Biol. 2008, 40:84-97.
32. Sato N., Imaizumi K., Manabe T., Taniguchi M., Hitomi J., Katayama T., Yoneda T., Morihara T., Yasuda Y., Takagi T., Kudo T., Tsuda T., Itoyama Y., Makifuchi T., Fraser P.E., St George-Hyslop P., Tohyama M. Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J. Biol. Chem. 2001, 276:2108-2114.
33. Schaeffer E.L., Figueiro M., Gattaz W.F. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics 2011, 66(Suppl. 1):45-54.
34. Schellenberg G.D., Montine T.J. The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol. 2012, 124:305-323.
35. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 1996, 2:864-870.
36. Shaner N.C., Campbell R.E., Steinbach P.A., Giepmans B.N., Palmer A.E., Tsien R.Y. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 2004, 22:1567-1572.
37. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 1997, 89:629-639.
38. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A., Haines J.L., Perkicak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
39. Shilling D., Mak D.O., Kang D.E., Foskett J.K. Lack of evidence for presenilins as endoplasmic reticulum Ca2+ leak channels. J. Biol. Chem. 2012, 287:10933-10944.
40. Smith I.F., Hitt B., Green K.N., Oddo S., LaFerla F.M. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J. Neurochem. 2005, 94:1711-1718.
41. Stutzmann G.E., Smith I., Caccamo A., Oddo S., Laferla F.M., Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 2006, 26:5180-5189.
42. Stutzmann G.E., Smith I., Caccamo A., Oddo S., Parker I., Laferla F. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Ann. N. Y. Acad. Sci. 2007, 1097:265-277.
43. Takeda T., Asahi M., Yamaguchi O., Hikoso S., Nakayama H., Kusakari Y., Kawai M., Hongo K., Higuchi Y., Kashiwase K., Watanabe T., Taniike M., Nakai A., Nishida K., Kurihara S., Donoviel D.B., Bernstein A., Tomita T., Iwatsubo T., Hori M., Otsu K. Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling. FASEB J. 2005, 19:2069-2071.
44. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., Obata K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2025-2030.
45. Tu H., Nelson O., Bezprozvanny A., Wang Z., Lee S.F., Hao Y.H., Serneels L., De Strooper B., Yu G., Bezprozvanny I. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006, 126:981-993.
46. Wehrens X.H., Marks A.R. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem. Sci. 2003, 28:671-678.
47. Westhoff J.H., Hwang S.Y., Duncan R.S., Ozawa F., Volpe P., Inokuchi K., Koulen P. Vesl/Homer proteins regulate ryanodine receptor type 2 function and intracellular calcium signaling. Cell Calcium 2003, 34:261-269.
48. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998, 279:234-237.
49. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 2007, 76:367-385.
50. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Sudhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.
51. Zhu L., et al. Modeling a ryanodine receptor N-terminal domain connecting the central vestibule and the corner clamp region. J. Biol. Chem. 2013, 288(2):903-914.